Altered plasma levels of nerve growth factor and transforming growth factor-β2 in type-1 diabetes mellitus

Sami T. Azar, Stella Major, Bared Safieh-Garabedian

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Nerve growth factor (NGF) and transforming growth factor-β2 (TGF-β2) are cytokines which have known immunological effects. An elevated level of NGF has been reported in certain autoimmune diseases, whereas TGF-β2 is an immunosuppressor which is known to play a role in regulating cell proliferation. A role of this cytokine has been proposed in the pathogenesis of type-1 diabetes mellitus (IDDM), but no clinical studies have yet measured its serum level in this disease. In this study we measured the levels of NGF and TGF-β2 in the sera of patients with IDDM (n = 26) and values were compared to those of age-matched normal subjects (n = 27) and also to patients with type-2 diabetes mellitus (NIDDM) (n = 26) with similar HbAlc levels and an equal duration of diabetes. Serum NGF levels were significantly elevated in IDDM patients compared to those of age-matched controls (p < .001) and NIDDM controls (p < .01). TGF-β2 levels were lower in IDDM patients when compared with the healthy control (p < .001) and the NIDDM control (p < .05). There was no correlation between the levels of NGF and TGF-β2. The duration of diabetes and the level of HbAlc did not affect the NGF and TGF-β2 levels in the IDDM patients. We conclude that an increase in NGF and a suppression in TGF-β2 levels are present in patients with type-1 diabetes mellitus and that both cytokines may play independent roles in the pathogenesis of this disease.

Original languageEnglish
Pages (from-to)361-366
Number of pages6
JournalBrain, Behavior, and Immunity
Volume13
Issue number4
DOIs
Publication statusPublished - Dec 1999
Externally publishedYes

Fingerprint

Transforming Growth Factors
Nerve Growth Factor
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Cytokines
Serum
Autoimmune Diseases
Cell Proliferation

Keywords

  • Autoimmunity
  • NGF
  • TGF-β2
  • Type-1 diabetes

ASJC Scopus subject areas

  • Immunology
  • Endocrine and Autonomic Systems
  • Behavioral Neuroscience

Cite this

Altered plasma levels of nerve growth factor and transforming growth factor-β2 in type-1 diabetes mellitus. / Azar, Sami T.; Major, Stella; Safieh-Garabedian, Bared.

In: Brain, Behavior, and Immunity, Vol. 13, No. 4, 12.1999, p. 361-366.

Research output: Contribution to journalArticle

@article{60e7ff24554b44e280079d2a8cfbf426,
title = "Altered plasma levels of nerve growth factor and transforming growth factor-β2 in type-1 diabetes mellitus",
abstract = "Nerve growth factor (NGF) and transforming growth factor-β2 (TGF-β2) are cytokines which have known immunological effects. An elevated level of NGF has been reported in certain autoimmune diseases, whereas TGF-β2 is an immunosuppressor which is known to play a role in regulating cell proliferation. A role of this cytokine has been proposed in the pathogenesis of type-1 diabetes mellitus (IDDM), but no clinical studies have yet measured its serum level in this disease. In this study we measured the levels of NGF and TGF-β2 in the sera of patients with IDDM (n = 26) and values were compared to those of age-matched normal subjects (n = 27) and also to patients with type-2 diabetes mellitus (NIDDM) (n = 26) with similar HbAlc levels and an equal duration of diabetes. Serum NGF levels were significantly elevated in IDDM patients compared to those of age-matched controls (p < .001) and NIDDM controls (p < .01). TGF-β2 levels were lower in IDDM patients when compared with the healthy control (p < .001) and the NIDDM control (p < .05). There was no correlation between the levels of NGF and TGF-β2. The duration of diabetes and the level of HbAlc did not affect the NGF and TGF-β2 levels in the IDDM patients. We conclude that an increase in NGF and a suppression in TGF-β2 levels are present in patients with type-1 diabetes mellitus and that both cytokines may play independent roles in the pathogenesis of this disease.",
keywords = "Autoimmunity, NGF, TGF-β2, Type-1 diabetes",
author = "Azar, {Sami T.} and Stella Major and Bared Safieh-Garabedian",
year = "1999",
month = "12",
doi = "10.1006/brbi.1999.0554",
language = "English",
volume = "13",
pages = "361--366",
journal = "Brain, Behavior, and Immunity",
issn = "0889-1591",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Altered plasma levels of nerve growth factor and transforming growth factor-β2 in type-1 diabetes mellitus

AU - Azar, Sami T.

AU - Major, Stella

AU - Safieh-Garabedian, Bared

PY - 1999/12

Y1 - 1999/12

N2 - Nerve growth factor (NGF) and transforming growth factor-β2 (TGF-β2) are cytokines which have known immunological effects. An elevated level of NGF has been reported in certain autoimmune diseases, whereas TGF-β2 is an immunosuppressor which is known to play a role in regulating cell proliferation. A role of this cytokine has been proposed in the pathogenesis of type-1 diabetes mellitus (IDDM), but no clinical studies have yet measured its serum level in this disease. In this study we measured the levels of NGF and TGF-β2 in the sera of patients with IDDM (n = 26) and values were compared to those of age-matched normal subjects (n = 27) and also to patients with type-2 diabetes mellitus (NIDDM) (n = 26) with similar HbAlc levels and an equal duration of diabetes. Serum NGF levels were significantly elevated in IDDM patients compared to those of age-matched controls (p < .001) and NIDDM controls (p < .01). TGF-β2 levels were lower in IDDM patients when compared with the healthy control (p < .001) and the NIDDM control (p < .05). There was no correlation between the levels of NGF and TGF-β2. The duration of diabetes and the level of HbAlc did not affect the NGF and TGF-β2 levels in the IDDM patients. We conclude that an increase in NGF and a suppression in TGF-β2 levels are present in patients with type-1 diabetes mellitus and that both cytokines may play independent roles in the pathogenesis of this disease.

AB - Nerve growth factor (NGF) and transforming growth factor-β2 (TGF-β2) are cytokines which have known immunological effects. An elevated level of NGF has been reported in certain autoimmune diseases, whereas TGF-β2 is an immunosuppressor which is known to play a role in regulating cell proliferation. A role of this cytokine has been proposed in the pathogenesis of type-1 diabetes mellitus (IDDM), but no clinical studies have yet measured its serum level in this disease. In this study we measured the levels of NGF and TGF-β2 in the sera of patients with IDDM (n = 26) and values were compared to those of age-matched normal subjects (n = 27) and also to patients with type-2 diabetes mellitus (NIDDM) (n = 26) with similar HbAlc levels and an equal duration of diabetes. Serum NGF levels were significantly elevated in IDDM patients compared to those of age-matched controls (p < .001) and NIDDM controls (p < .01). TGF-β2 levels were lower in IDDM patients when compared with the healthy control (p < .001) and the NIDDM control (p < .05). There was no correlation between the levels of NGF and TGF-β2. The duration of diabetes and the level of HbAlc did not affect the NGF and TGF-β2 levels in the IDDM patients. We conclude that an increase in NGF and a suppression in TGF-β2 levels are present in patients with type-1 diabetes mellitus and that both cytokines may play independent roles in the pathogenesis of this disease.

KW - Autoimmunity

KW - NGF

KW - TGF-β2

KW - Type-1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=0033406199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033406199&partnerID=8YFLogxK

U2 - 10.1006/brbi.1999.0554

DO - 10.1006/brbi.1999.0554

M3 - Article

VL - 13

SP - 361

EP - 366

JO - Brain, Behavior, and Immunity

JF - Brain, Behavior, and Immunity

SN - 0889-1591

IS - 4

ER -